Market Cap 218.05B
Revenue (ttm) 41.95B
Net Income (ttm) 13.40B
EPS (ttm) N/A
PE Ratio 25.11
Forward PE 24.33
Profit Margin 31.95%
Debt to Equity Ratio 0.25
Volume 4,361,096
Avg Vol 6,351,652
Day's Range N/A - N/A
Shares Out 1.74B
Stochastic %K 41%
Beta 0.72
Analysts Strong Sell
Price Target $146.69

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement th...

Industry: Medical Devices
Sector: Healthcare
Phone: 224 667 6100
Address:
100 Abbott Park Road, Abbott Park, North Chicago, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 1:22 AM
Actionable Trade Alert for $ABT: Market Context: $ABT is currently trading at $125.4, with an RSI of 39.53 indicating it is nearing oversold conditions. The stock is below its 30-day (126.76) and 50-day (128.8) moving averages, suggesting bearish momentum. However, the proximity to the 60-day low of 122.1 presents a potential reversal opportunity. Directional Bias: Given the RSI and the recent price action, we anticipate a bullish reversal. The stock has room to move toward its recent high of 137.49, making this a favorable setup. Trade Plan: - Suggested Entry: $125.4 - Stop Loss: $122.1 (below the 60D low) - Take Profit Targets: 1. TP1: $128.0 (2.1% gain) 2. TP2: $132.0 (5.3% gain) 3. TP3: $147.0 (17.2% gain) This plan offers a solid risk-reward ratio with potential for over 17% ROI on the third target. Monitor closely for price action around the targets. https://privateprofiteers.com
0 · Reply
CharlyBue
CharlyBue Dec. 5 at 10:42 PM
$LXRX $ABT The U.S. Food and Drug Administration is warning people to stop using certain types of glucose monitor sensors after the company that makes them, Abbott Diabetes Care, said the devices were linked to seven deaths and more than 700 injuries?. x it‘s time, go for LXRX 👊 🚀
0 · Reply
BMWLTWM3
BMWLTWM3 Dec. 5 at 6:03 PM
0 · Reply
BMWLTWM3
BMWLTWM3 Dec. 5 at 6:03 PM
$ABT any chatter about Abbott acquiring Senseonics Eversense 365 CGM ..? Abbott bought 40m shares in May 2025.
0 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Dec. 5 at 4:36 AM
$ABT not good wen 50% off
0 · Reply
JInvestTrade
JInvestTrade Dec. 5 at 4:08 AM
$SENS $DXCM $ABT $PODD $TNDM https://www.linkedin.com/posts/gingervieira_implantable-cgms-answering-6-faqs-activity-7401628816089190400-RW9v?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
JInvestTrade
JInvestTrade Dec. 5 at 4:04 AM
$SENS $DXCM $ABT $PODD $TNDM https://www.linkedin.com/posts/sarah-drayer-566056255_honored-to-work-alongside-a-team-and-dr-activity-7399191742199271424-W_sj?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
JInvestTrade
JInvestTrade Dec. 5 at 4:03 AM
$SENS $DXCM $ABT https://www.linkedin.com/posts/regina-bonnette-2100123a_eversense-diabetescare-cgm-activity-7397328059831525376-V4zW?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Dec. 5 at 4:01 AM
$ABT wen 25?
0 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Dec. 5 at 4:00 AM
$ABT The U.S. Food and Drug Administration is warning people to stop using certain types of glucose monitor sensors after the company that makes them, Abbott Diabetes Care, said the devices were linked to seven deaths and more than 700 injuries. wtf
0 · Reply
Latest News on ABT
This Top Dividend King Just Became an Even Better Buy

Nov 30, 2025, 2:05 AM EST - 6 days ago

This Top Dividend King Just Became an Even Better Buy


Best Dividend Aristocrats For December 2025

Nov 29, 2025, 8:02 AM EST - 6 days ago

Best Dividend Aristocrats For December 2025

ABBV ADM ADP AFL ALB AMCR AOS


Top 2 Healthcare Stocks Every New Investor Should Know

Nov 21, 2025, 8:15 AM EST - 14 days ago

Top 2 Healthcare Stocks Every New Investor Should Know

DXCM


2 Fantastic Dividend Stocks to Buy and Hold Forever

Nov 21, 2025, 5:47 AM EST - 14 days ago

2 Fantastic Dividend Stocks to Buy and Hold Forever

MDT


Abbott to Acquire Exact Sciences for $21 Billion

Nov 20, 2025, 7:46 AM EST - 15 days ago

Abbott to Acquire Exact Sciences for $21 Billion

EXAS


2 Top Dividend Stocks to Buy and Hold Forever

Nov 10, 2025, 7:30 AM EST - 25 days ago

2 Top Dividend Stocks to Buy and Hold Forever

MSFT


10 Defensive Stocks with Market-Beating Yields

Nov 8, 2025, 1:10 PM EST - 27 days ago

10 Defensive Stocks with Market-Beating Yields

DG


Best Dividend Aristocrats For November 2025

Nov 1, 2025, 10:25 AM EDT - 4 weeks ago

Best Dividend Aristocrats For November 2025

ABBV ADM ADP AMCR AOS ATO BDX


Best Dividend Kings: October 2025

Oct 29, 2025, 5:11 AM EDT - 5 weeks ago

Best Dividend Kings: October 2025

ABBV ABM ADM ADP AWR BDX BKH


Abbott: GLP-1 Beneficiary - A Dividend Raise May Be Coming

Oct 18, 2025, 9:39 AM EDT - 6 weeks ago

Abbott: GLP-1 Beneficiary - A Dividend Raise May Be Coming


Gold Gains Over 1%; Abbott Shares Fall After Q3 Results

Oct 15, 2025, 2:20 PM EDT - 7 weeks ago

Gold Gains Over 1%; Abbott Shares Fall After Q3 Results


Abbott Laboratories (ABT) Q3 2025 Earnings Call Transcript

Oct 15, 2025, 1:36 PM EDT - 7 weeks ago

Abbott Laboratories (ABT) Q3 2025 Earnings Call Transcript


1 No-Brainer Dividend Stock to Buy and Hold Forever

Oct 15, 2025, 9:45 AM EDT - 7 weeks ago

1 No-Brainer Dividend Stock to Buy and Hold Forever


Abbott Labs Posts Higher Sales, Reaffirms Outlook

Oct 15, 2025, 7:55 AM EDT - 7 weeks ago

Abbott Labs Posts Higher Sales, Reaffirms Outlook


Best Dividend Aristocrats For October 2025

Sep 28, 2025, 1:00 AM EDT - 2 months ago

Best Dividend Aristocrats For October 2025

ADP ATO BDX BEN CAH CHRW CL


Abbott Hosts Conference Call for Third-Quarter Earnings

Sep 24, 2025, 9:00 AM EDT - 2 months ago

Abbott Hosts Conference Call for Third-Quarter Earnings


Don't Overlook These 2 Dividend Kings in Today's Volatile Market

Sep 21, 2025, 7:05 PM EDT - 2 months ago

Don't Overlook These 2 Dividend Kings in Today's Volatile Market

KO


Daily Dividend Report: Kroger, TXN, Philip Morris, Abbott, GE

Sep 19, 2025, 2:25 PM EDT - 2 months ago

Daily Dividend Report: Kroger, TXN, Philip Morris, Abbott, GE

GE KR PM


1 Dividend King To Hold And 2 Worth Buying Now

Sep 19, 2025, 12:37 PM EDT - 2 months ago

1 Dividend King To Hold And 2 Worth Buying Now

FRT PPG


Abbott Declares 407th Consecutive Quarterly Dividend

Sep 19, 2025, 9:00 AM EDT - 2 months ago

Abbott Declares 407th Consecutive Quarterly Dividend


8 Dividend Growth Stocks Every Investor Should Consider

Sep 19, 2025, 5:45 AM EDT - 2 months ago

8 Dividend Growth Stocks Every Investor Should Consider

GWW JNJ KO LOW MO PG PH


3 No-Brainer Dividend Stocks to Buy in September

Sep 13, 2025, 6:42 AM EDT - 2 months ago

3 No-Brainer Dividend Stocks to Buy in September

ABBV LLY


Inside Abbott's big bet on the future of healthcare

Sep 6, 2025, 9:01 AM EDT - 3 months ago

Inside Abbott's big bet on the future of healthcare


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 1:22 AM
Actionable Trade Alert for $ABT: Market Context: $ABT is currently trading at $125.4, with an RSI of 39.53 indicating it is nearing oversold conditions. The stock is below its 30-day (126.76) and 50-day (128.8) moving averages, suggesting bearish momentum. However, the proximity to the 60-day low of 122.1 presents a potential reversal opportunity. Directional Bias: Given the RSI and the recent price action, we anticipate a bullish reversal. The stock has room to move toward its recent high of 137.49, making this a favorable setup. Trade Plan: - Suggested Entry: $125.4 - Stop Loss: $122.1 (below the 60D low) - Take Profit Targets: 1. TP1: $128.0 (2.1% gain) 2. TP2: $132.0 (5.3% gain) 3. TP3: $147.0 (17.2% gain) This plan offers a solid risk-reward ratio with potential for over 17% ROI on the third target. Monitor closely for price action around the targets. https://privateprofiteers.com
0 · Reply
CharlyBue
CharlyBue Dec. 5 at 10:42 PM
$LXRX $ABT The U.S. Food and Drug Administration is warning people to stop using certain types of glucose monitor sensors after the company that makes them, Abbott Diabetes Care, said the devices were linked to seven deaths and more than 700 injuries?. x it‘s time, go for LXRX 👊 🚀
0 · Reply
BMWLTWM3
BMWLTWM3 Dec. 5 at 6:03 PM
0 · Reply
BMWLTWM3
BMWLTWM3 Dec. 5 at 6:03 PM
$ABT any chatter about Abbott acquiring Senseonics Eversense 365 CGM ..? Abbott bought 40m shares in May 2025.
0 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Dec. 5 at 4:36 AM
$ABT not good wen 50% off
0 · Reply
JInvestTrade
JInvestTrade Dec. 5 at 4:08 AM
$SENS $DXCM $ABT $PODD $TNDM https://www.linkedin.com/posts/gingervieira_implantable-cgms-answering-6-faqs-activity-7401628816089190400-RW9v?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
JInvestTrade
JInvestTrade Dec. 5 at 4:04 AM
$SENS $DXCM $ABT $PODD $TNDM https://www.linkedin.com/posts/sarah-drayer-566056255_honored-to-work-alongside-a-team-and-dr-activity-7399191742199271424-W_sj?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
JInvestTrade
JInvestTrade Dec. 5 at 4:03 AM
$SENS $DXCM $ABT https://www.linkedin.com/posts/regina-bonnette-2100123a_eversense-diabetescare-cgm-activity-7397328059831525376-V4zW?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Dec. 5 at 4:01 AM
$ABT wen 25?
0 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Dec. 5 at 4:00 AM
$ABT The U.S. Food and Drug Administration is warning people to stop using certain types of glucose monitor sensors after the company that makes them, Abbott Diabetes Care, said the devices were linked to seven deaths and more than 700 injuries. wtf
0 · Reply
RunnerSignals
RunnerSignals Dec. 4 at 9:24 PM
Today Top Dip-to-Rip Stocks $DVLT $SNDK $PCG $PSKY $ABT started red but ripped into the green
0 · Reply
Oldpuck
Oldpuck Dec. 4 at 5:59 PM
$ABT Ever since ABT bought that company it has been down, down, down
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 4 at 7:53 AM
Hedge Alert Live - Protect Your Portfolio Contract: $ABT $125.00 Put · DEC 12, 2025 Exp Entry Price: $1.47 - $1.54 Exit Price Target: $3.31 Profit Margin: +125% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
ckjamesst
ckjamesst Dec. 3 at 2:02 PM
$ABT I can see abt moving towards 140 by eoy
1 · Reply
ckjamesst
ckjamesst Dec. 3 at 1:56 PM
$ABT abt is undervalue at this point… what you guys think ?
0 · Reply
ckjamesst
ckjamesst Dec. 3 at 11:42 AM
$ABT 128 should be broken to go higher or 130 till then bearish
0 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Dec. 3 at 3:40 AM
$ABT As of November 14, 2025, Abbott has reported 736 serious injuries and seven deaths associated with this issue," the FDA said
0 · Reply
BioTechHealthX
BioTechHealthX Dec. 3 at 1:22 AM
$ABT Abbott Laboratories delivers an impressive 21% EPS growth over the last three years, reinforcing NYSE:ABT as one of the strongest healthcare stocks to buy. Discover how Abbott’s $44B revenue base and global medical device dominance fuel long-term upside. https://biotechhealthx.com/biotech-news/abbott-laboratories-abt-posts-stunning-21-eps-growth-is-this-the-strongest-healthcare-stock-of-2025/
0 · Reply
ItsOkImANurse
ItsOkImANurse Dec. 3 at 12:21 AM
$DXCM $ABT client deaths are not good for profits or product adoption. Got this alert this morning about Abbotts freestyle Libre
0 · Reply
ckjamesst
ckjamesst Dec. 3 at 12:11 AM
$ABT abt goona fly
0 · Reply
ckjamesst
ckjamesst Dec. 2 at 11:31 PM
$ABT 130+ tomorrow healthcare stock are moving
0 · Reply
ckjamesst
ckjamesst Dec. 2 at 9:37 PM
$ABT this will fly
0 · Reply